Immune Checkpoint Inhibitors for Treating Advanced CSCC Immune Checkpoint Inhibitors for Treating Advanced CSCC
An immune-checkpoint inhibitor is the first systemic drug approved for advanced cutaneous squamous cell carcinomas--paving the way for further immunotherapies against CSCC.American Journal of Clinical Dermatology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news
More News: Cancer & Oncology | Carcinoma | Dermatology | Health | Immunotherapy | Skin | Squamous Cell Carcinoma